Stockreport

Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4

INNOVATION PHARMACEUTICAL  (IPIX) 
US:NASDAQ Investor Relations: ipharminc.com/press-release
PDF WAKEFIELD, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to [Read more]